The biotechnology research and experimental development turnover in France showed significant variations from 2013 to 2023. Starting at 1.97 billion euros in 2013, it experienced peaks and troughs, with a notable rise to 3.67 billion euros in 2017 and a steep decline to 1.23 billion euros in 2018. By 2023, the turnover had steadied to 1.54 billion euros, showing marginal growth over the previous years. The annual variations illustrate periods of volatility, such as the considerable increase in 2017 and a sharp drop in 2018. Over the past five years, the compound annual growth rate (CAGR) was a modest 4.62%, showing a stabilizing trend post the significant drop in 2018.
Looking ahead, the forecast indicates a gradual increase in turnover, with a CAGR of 1.16% expected from 2024 to 2028. Key future trends to watch include advancements in biotechnology research, increased investment in experimental development, and potential government support to foster innovation. Focus will also be on how the sector adapitates to emerging technologies and market demands, which are critical for sustained growth.
